Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Clinical trial NCT01600014 · COMPLETED

Trial details

NCT number: NCT01600014
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2012-05-01
Primary completion: 2014-02-01
Enrollment: 463

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.